Safety evaluation of nonoxynol-9 gel in women at low risk of HIV infection

AIDS

Volumn 12, Issue 4, 1998, Pages 433-437

  Van Damme, Lut ^e,f   Niruthisard, Somchai ^a   Atisook, Ronachai ^b   Boer, Kees ^c   Dally, Len ^d   Laga, Marie ^e   Lange, Joep M A ^c   Karam, Mark ^d   Perriens, Joseph H ^d  

^a KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

^e Intervention Unit   (Thailand)

^f INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

Colposcopy; Low risk women; Microbicide; Nonoxynol 9; Safety; Toxicity; Trial

Indexed keywords

COL 1492; NONOXINOL 9; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BELGIUM; CLINICAL TRIAL; COLPOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; ERYTHEMA; FEMALE; GENITAL ULCER; GYNECOLOGIC DISEASE; HUMAN; HUMAN EXPERIMENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVAGINAL DRUG ADMINISTRATION; MULTICENTER STUDY; NETHERLANDS; NORMAL HUMAN; PETECHIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THAILAND; TREATMENT OUTCOME; VAGINA DISCHARGE;

EID: 0032485243     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199804000-00013     Document Type: Article

References (22)

1. Stein ZA: HIV prevention: the need for methods women can use. Am J Public Health 1990, 80:460-462.
2. Global Programme on AIDS, World Health Organization: Report on a Meeting on the Development of Vaginal Microbicides for the Prevention of Heterosexual Transmission of HIV [Document WHO/GPA/RID/CRD/94.1;11-13 November 1993]. Geneva: GPA/WHO; 1993.
3. Stone AB, Hitchcock PJ: Vaginal microbicides for preventing the sexual transmission of HIV. AIDS 1994, 8 (suppl 1):S285-S293.
4. Elias CJ, Heise LL: Challenges for the development of female-controlled vaginal microbicides. AIDS 1994, 8:1-9.
5. Weir SS, Feldblum PJ, Zekeng L, Roddy RE: The use of nonoxynol-9 for protection against cervical gonorrhea. Am J Public Health 1994, 84:910-914.
6. Niruthisard S, Roddy RE, Chutivongse S: Use of nonoxynol-9 and reduction in rate of gonococcal and chlamydial cervical infections. Lancet 1992, 339:1371-1375.
7. Louv WC, Austin H, Alexander WJ, Stagno S, Cheeks J: A clinical trial of nonoxynol-9 for preventing gonococcal and chlamydial infections. J Infect Dis 1988, 158:518-523.
8. Malkovsky M, Newell A, Dalgleish AG: Inactivation of HIV by nonoxynol-9 [letter]. Lancet 1988; i:645.
9. Hicks DR, Martin LA, Getchell JP, et al.: Inactivation of HTLV-II/LAV-infected cultures of normal human lymphocytes by nonoxynol-9 in vitro. Lancet 1985, ii:1422-1423.
10. Zekeng L, Feldblum PJ, Oliver RM, Kapute L: Barrier contraceptive use and HIV infection among high-risk women in Cameroon. AIDS 1993, 7:725-731.
11. Feldblum P, Hira S, Coodwin S, Kamanga J, Mukelabaie G: Efficacy of spermicide use and condom use by HIV-discordant couples in Zambia. VIII International Conference on AIDS/III STD World Congress. Amsterdam, July 1992 [abstract WeC1085].
12. Kreiss J, Ngugi E, Holmes K, et al.: Efficacy of nonoxynol-9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. JAMA 1992, 268:477-482.
13. Cameron DW, Lourdes JD, Gregory MM. et al.: Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men. Lancet 1989, ii:403-407.
14. Plummer FA, Simonsen JN, Cameron DW, et al.: Co-factors in female-to-male sexual transmission of HIV. J Infect Dis 1991, 163:233-239.
15. Plourde PJ, Pepin J, Agoki E, et al.: Human immunodeficiency virus type 1 seroconversion in women with genital ulcers. J Infect Dis 1994, 170:313-317.
16. Ghys PD, Diallo MO, Ettiegne-Traore V, et al.: Genital ulcers associated with human immunodeficiency virus-related immunosuppression in female sex workers in Abidjan, Ivory Coast. J Infect Dis 1995, 172:1371-1374.
17. WHO/GPA/RID/CRD: Manual for the Standardization of Colposcopy for the Evaluation of Vaginally Administered Products. Geneva: World Health Organization; 1995.
18. Roddy RE, Cordero M, Cordero C, Fortney JA: A dosing study of nonoxynol-9 and genital irritation, Int J STD AIDS 1993, 4:165-170.
19. Niruthisard S, Roddy RE, Chutivongse S: The effects of frequent nonoxynol-9 use on the vaginal and cervical mucosa. Sex Transm Dis 1991, 18:176-179.
20. Weir SS, Roddy RE, Zekeng L, Feldblum PJ: Nonoxynol-9 use, genital ulcers, and HIV infection in a cohort of sex workers. Cenitourin Med 1995, 71:78-81.
21. Martin HL, Stevens CE, Richardson BA, et al.: Safety of a nonoxynol-9 vaginal gel in Kenyan prostitutes. Sex Transm Dis 1997, 24:279-283.
22. Roddy RE, Zekeng L, Ryan KA, Tamoufe A, Weir SS: A randomized controlled trial of the effect of nonoxynol-9 film use on male-to-female transmission of HIV-1. National Conference on Women and HIV. Pasadena, May 1997 [abstract 215.3].